Bharat Immunologicals (India) Financial Indicators Patterns

BIBCL -- India Stock  

INR 8.07  0.17  2.15%

Please use Bharat Immunologicals fundamental data analysis to find out if markets are presently mispricing the company. We found twenty-three available fundamental indicators for Bharat Immunologicals Biologicals Corp Ltd which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all Bharat Immunologicals fundamentals including its Operating Margin, Revenue, Debt to Equity, as well as the relationship between Price to Earning and Net Income . Use Bharat Immunologicals to enhance returns of your portfolios. The stock experiences unexpected upward trend. Watch out for market signals. Check odds of Bharat Immunologicals to be traded at 9.68 in 30 days.

Chance of Financial Distress

Bharat Immunologicals Biologicals Corp Ltd has less than 47 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info

Bharat Immunologicals Company Summary

Bharat Immunologicals competes with Infosys, Glenmark Pharmaceuticals, and SVP GLOBAL. Bharat Immunologicals Biologicals Corporation Limited, a biotechnology company, manufactures and markets a range of pharmaceuticals products in India. The company was founded in 1989 and is based in Bulandshahr, India. Bharat Immunologicals operates under Biotechnology classification in India and is traded on Bombay Stock Exchange.

Bharat Immunologicals Current Ratio vs Operating Margin

Bharat Immunologicals Biologicals Corp Ltd is number one stock in current ratio category among related companies. It is number one stock in operating margin category among related companies .

Bharat Immunologicals Market Fundamentals

 Change(%) 2.15%

Bharat Immunologicals June 20, 2019 Opportunity Range

Check also Trending Equities. Please also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.